Molecular mechanism of G2 phase cell cycle arrest in tumor cellsLin Lin*, Zhou Juying. *Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou 215000, China

Abstract

Lin Lin, Zhou Juying. Molecular mechanism of G2 phase cell cycle arrest in tumor cellsLin Lin*, Zhou Juying. *Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou 215000, China[J]. Journal of International Oncology, 2017, 44(3): 186-189.

References

［1］ Meng X, Laidler LL, Kosmacek EA, et al. Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with nonfunctional p53［J］. Gynecol Oncol, 2013, 128(3): 461-469. DOI: 10.1016/j.ygyno.2012.11.004. ［2］ Larsen DH, Stucki M. Nucleolar responses to DNA doublestrand breaks ［J］. Nucleic Acids Res, 2016, 44(2): 538544. DOI: 10.1093/nar/gkv1312. ［3］ De Cicco M, Rahim MS, Dames SA. Regulation of the target of rapamycin and other phosphatidylinositol 3kinaserelated kinases by membrane targeting［J］. Membranes, 2015, 5(4): 553-575. DOI: 10.3390/membranes5040553. ［4］ Malaquin N, CarrierLeclerc A, Dessureault M, et al. DDRmediated crosstalk between DNAdamaged cells and their microenvironment［J］. Front Genet, 2015, 6: 94. DOI: 10.3389/fgene.2015.00094. ［5］ Siddiqui MS, Franois M, Fenech MF, et al. Persistent γH2AX: a promising molecular marker of DNA damage and aging［J］. Mutat Res Rev Mutat Res, 2015, 766: 1-19. DOI: 10.1016/j.mrrev.2015.07.001. ［6］ Monsalve DM, CampilloMarcos I, Salzano M, et al. VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage［J］. Biochim Biophys Acta, 2016, 1863(4): 760-769. DOI: 10.1016/j.bbamcr.2016.02.005. ［7］ Khongkow P, Karunarathna U, Khongkow M, et al. FOXM1 targets NBS1 to regulate DNA damageinduced senescence and epirubicin resistance［J］. Oncogene, 2014, 33(32): 4144-4155. DOI: 10.1038/onc.2013.457. ［8］ Park S, Kang JM, Kim SJ, et al. Smad7 enhances ATM activity by facilitating the interaction between ATM and Mre11Rad50Nbs1 complex in DNA doublestrand break repair［J］. Cell Mol Life Sci, 2015, 72(3): 583- 596. DOI: 10.1007/s000180141687z. ［9］ Liu XY, Zha S. ATMIN: a new tumor suppressor in developing B cells［J ］. Cancer Cell, 2011, 19(5): 569-570. DOI: 10.1016/j.ccr.2011.05.002. ［10］ Loizou JI, Sancho R, Kanu N, et al. ATMIN is required for maintenance of genomic stability and suppression of B cell lymphoma［J］. Cancer Cell, 2011, 19(5): 587-600. DOI: 10.1016/j.ccr.2011.03.022. ［11］ Rizzo A, Salvati E, Porru M, et al. Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATRdependent ATM signaling pathway［J］. Nucleic Acids Res, 2009, 37(16): 5353-5364. DOI: 10.1093/nar/gkp582. ［12］ Spagnolo L, Barbeau J, Curtin NJ, et al. Visualization of a DNAPK/PARP1 complex［J］. Nucleic Acids Res, 2012, 40(9): 4168-4177. DOI: 10.1093/nar/gkr1231. ［13］ VidalEychenie S, Decaillet C, Basbous JA. DNA structurespecific priming of ATR activation by DNAPK［J］. J Cell Biol, 2013, 202(3): 421- 429. DOI: 10.1083/jcb.201304139. ［14］ Xue L, Yu D, Furusawa Y, et al. ATMdependent hyperradiosensitivity in mammalian cells irradiated by heavy ions［J］. Int J Radiat Oncol Biol Phys, 2009, 75(1): 235-243. DOI: 10.1016/j.ijrobp.2009.04.088. ［15］ Cui YX, Palii SS, Innes CL, et al. Depletion of ATR selectively sensitizes ATMdeficient human mammary epithelial cells to ionizing radiation and DNAdamaging agents［J］. Cell Cycle, 2014, 13(22): 3541-3550. DOI: 10.4161/15384101.2014.960729. ［16］ Weber AM, Ryan AJ. ATM and ATR as therapeutic targets in cancer［J］ . Pharmacol Ther, 2015, 149: 124-138. DOI: 10.1016/j.pharmthera.2014.12.001. ［17］ Wang XQ, Redpath JL, Fan ST, et al. ATR dependent activation of Chk2 ［J］. J Cell Physiol, 2006, 208(3): 613-619. DOI: 10.1002/jcp.20700. ［18］ Zhang J, Gao G, Chen L, et al. Hydrogen peroxide/ATRChk2 activation mediates p53 protein stabilization and anticancer activity of cheliensisin a in human cancer cells［J］. Oncotarget, 2014, 5(3): 841-852. ［19］ Niida H, Murata K, Shimada M, et al. Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo［J］. EMBO J, 2010, 29(20): 3558-3570. DOI: 10.1038/emboj.2010.218. ［20］ Manic G, Obrist F, Sistigu A, et al. Trial watch: targeting ATMCHK2 and ATRCHK1 pathways for anticancer therapy［J］. Mol Cell Oncol, 2015, 2(4): e1012976. DOI: 10.1080/23723556.2015.1012976. ［21］ Lavecchia A, Di Giovanni C, Novellino E. CDC25 phosphatase inhibitors: an update［J］. Mini Rev Med Chem, 2012, 12(1): 62-73. ［22］ Wu YJ, Jan YJ, Ko BS, et al. Involvement of 1433 proteins in regulating tumor progression of hepatocellular carcinoma［J］. Cancers (Basel), 2015, 7(2): 1022-1036. DOI: 10.3390/cancers7020822. ［23］ Agius E, BelVialar S, Bonnet F, et al. Cell cycle and cell fate in the developing nervous system: the role of CDC25B phosphatase［J］. Cell Tissue Res, 2015, 359(1): 201-213. DOI: 10.1007/s0044101419982. ［24］ Vriend LE, De Witt Hamer PC, Van Noorden CJ, et al. WEE1 inhibition and genomic instability in cancer［J］. Biochim Biophys Acta, 2013, 1836 (2): 227-235. DOI: 10.1016/j.bbcan.2013.05.002. ［25］ Li S, Zhang Y, Xu W. Developments of pololike kinase 1 (Plk1) inhibitors as anticancer agents［J］. Mini Rev Med Chem, 2013, 13(14): 2014-2025. ［26］ Wang LM, Lv WW, Zuo D, et al. Characteristics of cyclin B and its potential role in regulating oogenesis in the red claw crayfish (cherax quadricarinatus)［J］. Genet Mol Res, 2015, 14(3): 10786-10798. DOI: 10.4238/2015.September.9.17.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing.Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients[J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun.Advances in anti-tumor drugs with new mechanisms of action[J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying.Research progress of habitat analysis in radiomics of malignant tumors[J]. Journal of International Oncology, 2024, 51(5): 292-297.

Molecular mechanism of G2 phase cell cycle arrest in tumor cellsLin Lin, Zhou Juying. Department of Radiation Oncology, First Affiliated Hospital of Soochow University, Suzhou 215000, China

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments